Date published: 2026-6-6

1-800-457-3801

SCBT Portrait Logo
Seach Input

quetiapine (CAS 111974-69-7)

5.0(1)
Write a reviewAsk a question

Alternate Names:
Ketipinor
CAS Number:
111974-69-7
Purity:
≥98%
Molecular Weight:
383.5
Molecular Formula:
C21H25N3O2S
Supplemental Information:
This is classified as a Dangerous Good for transport and may be subject to additional shipping charges.
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

Quetiapine functions as a serotonin and dopamine receptor antagonist. It acts by blocking the binding of serotonin and dopamine to their respective receptors in the brain. This action results in a decrease in the effects of these neurotransmitters, leading to altered neurotransmission. Quetiapine inhibits the activity of serotonin and dopamine receptors, thereby modulating the transmission of signals within the central nervous system. This modulation of neurotransmission is thought to contribute to the observed effects of quetiapine in experimental applications. Quetiapine′s mechanism of action involves its interaction with specific receptors in the brain, leading to the modulation of neurotransmitter activity.


quetiapine (CAS 111974-69-7) References

  1. Quetiapine for schizophrenia.  |  Srisurapanont, M., et al. 2000. Cochrane Database Syst Rev. CD000967. PMID: 10796560
  2. Quetiapine: a review of its use in the management of bipolar depression.  |  Sanford, M. and Keating, GM. 2012. CNS Drugs. 26: 435-60. PMID: 22519923
  3. Quetiapine for the treatment of delirium.  |  Hawkins, SB., et al. 2013. J Hosp Med. 8: 215-20. PMID: 23468358
  4. Quetiapine for insomnia: A review of the literature.  |  Anderson, SL. and Vande Griend, JP. 2014. Am J Health Syst Pharm. 71: 394-402. PMID: 24534594
  5. Quetiapine for acute bipolar depression: a systematic review and meta-analysis.  |  Suttajit, S., et al. 2014. Drug Des Devel Ther. 8: 827-38. PMID: 25028535
  6. Quetiapine safety in older adults: a systematic literature review.  |  El-Saifi, N., et al. 2016. J Clin Pharm Ther. 41: 7-18. PMID: 26813985
  7. Quetiapine monotherapy in acute treatment of generalized anxiety disorder: a systematic review and meta-analysis of randomized controlled trials.  |  Maneeton, N., et al. 2016. Drug Des Devel Ther. 10: 259-76. PMID: 26834458
  8. Quetiapine Misuse and Abuse: Is it an Atypical Paradigm of Drug Seeking Behavior?  |  Kim, S., et al. 2017. J Res Pharm Pract. 6: 12-15. PMID: 28331860
  9. Quetiapine-Associated Myopericarditis.  |  Bhogal, S., et al. 2018. Am J Ther. 25: e578-e579. PMID: 28953514
  10. Quetiapine-Induced Central Hypothyroidism.  |  Zenno, A. and Leschek, E. 2020. J Am Acad Child Adolesc Psychiatry. 59: 575-576. PMID: 32036034
  11. Quetiapine withdrawal: A systematic review.  |  Monahan, K., et al. 2021. Aust N Z J Psychiatry. 55: 772-783. PMID: 33059460
  12. Quetiapine for primary insomnia: Consider the risks.  |  Modesto-Lowe, V., et al. 2021. Cleve Clin J Med. 88: 286-294. PMID: 33941603
  13. Who prescribes quetiapine in Denmark?  |  Højlund, M., et al. 2022. Br J Clin Pharmacol. 88: 4224-4229. PMID: 35535441

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

quetiapine, 2.5 mg

sc-280046
2.5 mg
$42.00

quetiapine, 25 mg

sc-280046A
25 mg
$292.00